Literature DB >> 15054576

[52-year old patient with recurrent syncope and temporary right precordial EKG-changes with fever].

R Caliskan1, M Zabel, B Witzenbichler, C Sticherling.   

Abstract

This case report highlights the importance of considering the differential diagnosis of a primary electrical cardiac disease in a patient with unexplained syncope. In the absence of positive findings in his cardiac and neurological work-up, the presented patient had been diagnosed with "cryptogenic" epilepsy. During a febrile episode, however, his 12-lead ECG showed ST-segment elevations in leads V(1) and V(2), typical for the Brugada-Syndrome. Hence, his antiepileptic medication was discontinued and the patient received an implantable defibrillator. Pathophysiology, diagnosis, risk stratification, as well as the treatment options for this disease of the cardiac sodium channel are reviewed.

Entities:  

Mesh:

Year:  2004        PMID: 15054576     DOI: 10.1007/s00108-004-1172-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

Review 1.  The Brugada syndrome: ionic basis and arrhythmia mechanisms.

Authors:  C Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2001-02

Review 2.  Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Authors:  Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

Review 3.  Brugada syndrome: a decade of progress.

Authors:  C Antzelevitch; P Brugada; J Brugada; R Brugada; W Shimizu; I Gussak; A R Perez Riera
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

4.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

5.  Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.

Authors:  W Shimizu; C Antzelevitch; K Suyama; T Kurita; A Taguchi; N Aihara; H Takaki; K Sunagawa; S Kamakura
Journal:  J Cardiovasc Electrophysiol       Date:  2000-12

6.  Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts.

Authors:  R Brugada; J Brugada; C Antzelevitch; G E Kirsch; D Potenza; J A Towbin; P Brugada
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

7.  Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families.

Authors:  S G Priori; C Napolitano; M Gasparini; C Pappone; P Della Bella; M Brignole; U Giordano; T Giovannini; C Menozzi; R Bloise; L Crotti; L Terreni; P J Schwartz
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

8.  Fever unmasking the Brugada syndrome.

Authors:  José Manuel Porres; Josep Brugada; Vicente Urbistondo; Francisco García; Karlos Reviejo; Pilar Marco
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

9.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

Authors:  P Brugada; J Brugada
Journal:  J Am Coll Cardiol       Date:  1992-11-15       Impact factor: 24.094

10.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.